18:0 DAP

• UNSPSC Description:

  18:0 DAP can be used to formulate lipid nanoparticles (LNPs), which mRNA is encapsulated in their core[1].

• Target Antigen:

  Liposome

• Type:

  Biochemical Assay Reagents

• Related Pathways:

  Metabolic Enzyme/Protease

• Applications:

  Neuroscience-Neuromodulation

• Field of Research:

  Neurological Disease

• Assay Protocol:

  https://www.medchemexpress.com/18-0-dap.html

• Solubility:

  10 mM in DMSO

• Smiles:

  CN(CC(OC(CCCCCCCCCCCCCCCCC)=O)COC(CCCCCCCCCCCCCCCCC)=O)C

• Molecular Weight:

  652.09

• References & Citations:

  [1]Patel S, et al. Lipid nanoparticles for delivery of messenger RNA to the back of the eye. J Control Release. 2019;303:91-100.

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported

• CAS Number:

  121315-93-3